As of 11:26am ET
| +0.05 / +11.63%|
The 2 analysts offering 12-month price forecasts for DelMar Pharmaceuticals Inc have a median target of 5.27, with a high estimate of 6.00 and a low estimate of 4.53. The median estimate represents a +996.88% increase from the last price of 0.48.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.